Taxol discovery
The company relies on third parties to manufacture, or to supply it with active ingredients necessary for it to manufacture certain products, including pravachol, plavix * , abilify * , erbitux * , coumadin, paraplatin, sustiva, taxol paclitaxel ; and videx videx ec.
Were visualized by autoradiography and quantified by optical densitometry. The amount of ER mRNA was normalized to the amount of the internal control 36B4, which is the cDNA of the human acidic ribosomal phosphoprotein PO. Isolation of nuclei Nuclei from MCF-7 cells were isolated after treatment by a method described previously Saceda et al. 1988 ; . Briefly, the cells were harvested in 5 ml PBS and pelleted by gentle centrifugation at 4 C. The pellet was resuspended in lysis buffer 10 mM Tris, pH 75, 10 mM NaCl, 3 mM MgCl2, and 05% NP-40 ; . After 5 min on ice, the cells were centrifuged at 500 g at 4 for 5 min. The pellet was again resuspended in 4 ml lysis buffer and centrifuged as described above. The pellet from the second centrifugation was resuspended in 500 l nuclei storage buffer 20 mM HEPES, 75 mM NaCl, 05 mM EDTA, 085 mM dithiothreitol DTT ; , 0125 mM phenylmethylsulfonylfluoride, and 50% glycerol ; . Nuclei were stored at 70 C until the transcription elongation assay was performed. Transcription elongation assay The nuclear transcription run-on assay was performed as previously described Saceda et al. 1988 ; . Nuclei were isolated at various times after administration of taxol as described above. Isolated nuclei were incubated with 32 P-UTP and unlabeled ATP, CTP, and GTP. Radiolabeled RNA transcripts were isolated and hybridized to an excess of denatured plasmid DNA immobilized on a nitrocellulose membrane. Denatured plasmids used for detection of specific transcripts were exon 1 of ER ribosomal protein PO, glyceraldehyde-3-phosphate dehydrogenase GAPDH ; , pS2, and PR. Autoradiographs were analyzed by densitometry and the background was subtracted. The results were normalized to the transcriptional level of the ribosomal protein PO gene. Total transcription Nuclei from MCF-7 cells were isolated after incubation with taxol at different intervals as described above. The nuclear transcription assay was performed as described above except that 5 Ci 3H-UTP were used instead of the 32 P-UTP. The transcription reaction was stopped by the addition of 10% trichloroacetic acid TCA ; containing 15 mM sodium pyrophosphate. After incubation on ice for 60 min, the samples were centrifuged at 15 000 g for 20 s. The pellets were washed three times with 3% TCA containing 15 mM sodium pyrophosphate at 4 C. The pellets were hydrolyzed with 04 M perchloric acid at 70 C for 20 min, followed by neutralization with 04 M NaOH. The total radioactivity released was counted in a liquid scintillation counter
Bristol-Myers Squibb Pharmaceuticals is recalling a number of batches of Taxol paclitaxel ; concentrate for solution for infusion 6 mg ml as a precautionary measure because of a potential lack of sterility assurance. Batch numbers and expiry dates of the affected 5ml 7 batches ; , 16.7ml 15 batches ; and 50ml 8 batches ; vials are available from the "Safety warnings, alerts and recalls" section of the Medicines and Healthcare products Regulatory Agency website mhra.gov ; . Medical information on 0800 7311736. Stock return enquiries on 01244 586244.
Taxol efficacy
That these are evoked by slower conducting descendingfibers cannot be excluded. In somecases, even later lamina VII negative waves that peakedat the sametime as the P4 cord dorsum potential could be seen Fig. 6A ; . In experimentswhere multiple isopotential mapswere made, the largest lamina VII negative field potentials were found in the L5 6 segments. The amplitude of the "early" and "late" field potentialsranged from 44-180 ~.LV mean, 96 t 43 pV ; and 31-230 pV mean, 80 ? 61 p.V ; , respectively. Isopotential mapswere generatedto provide a graphical representationof the probable locations of the neuronsproducing the laminaeVI VII field potentials Figs. 6, 8 ; . Single or multiple current sinks could be found in these laminae seeFigs. 6, 8 ; . The relative amplitudes the different current sinkscould differ of substantially Fig. 6A ; . Lamina VIII. Short-latency, MLR-evoked field potentialswere observedin lamina VIII of the L4-7 spinal segments Figs. 5AC, 6A ; . The segmental latency of the earliestlamina VIII potentials showedmono- and disynaptic linkages Fig. 7 ; ranging between 0.2 and 3.4 msecfrom the peak of the volley P1 potentials 1.4 ? 0.8 msec, meanand SD ; . The onsetof the earliestlamina VIII field potentials was usually at or just after the onsetof the P2 cord dorsumpotential and the onset of the earliest laminae VI VII negative field potentials Figs. 5A, C; 6A ; . The latency from the time of the MLR stimuluswas 5.0 + 1.0 msec. The monosynapticlamina VIII field potentialspeakedat the apex of the P2 or P3 cord dorsumpotentials, whereas disynaptic VIII the fields peaked after the apex of the P3 wave. The latencies of onset of the earliest lamina VIII field potentials in the most rostra1segments were either shorter or approximately the same asthoseoccurring in more caudal segments. Where the latencies are similar, a slowing of conduction in the terminal branchesin the rostra1segments may be the explanation. A secondor "late" lamina VIII negative field potential was sometimes observed2.1-3.2 msecfollowing the first laminaVIII field potential in the L4-6 spinal segments. The locations of the current sinks of theselater lamina VIII field potentials were the.
Table 8. Estramustine plus a taxane Estramustine plus paclitaxel taxol ; Estramustine 600 mg m2 day continuously ; plus paclitaxel 120 mg m2 by 96 hour infusion on days 1 to 4 every 21 days ; [47]. Objective response rate 45% 4 of 9 patients with measurable soft tissue disease ; . PSA response 53% 17 of 32 patients with elevated pre-treatment PSA level ; . Estramustine plus docetaxol taxotere ; Estramustine 10 mg kg day p.o. days 1-5 ; plus taxotere 60-80 mg m2 i.v. on day 2 ; every 21 days [48]. 28% 5 of 18 patients ; with measurable disease had partial response. 63% 21 of 33 ; had 50% or greater decline in serum PSA. 53% 8 of 15 patients ; were able to discontinue their pain medications.
Occurrence in patients who had a cerebral stroke before. The annual occurrence rate of repeated cerebral stroke on the same side with patients with narrowed cerebrovascular reserve capacity is estimated to be 11-18 percent, in contrast with the patients with maintained reserve capacity where it is only 0-2.2 percent. Though it is without doubt that the probability of another cerebral stroke is higher with patients with symptoms than with the ones without symptoms, the question arises whether the recurring cerebral stroke is really caused by the narrowed reserve capacity and why symptomatic ICA stenosis patients are less endangered, because the disease or the lack of cerebrovascular reserve capacity are also measurable in this group of patients. In our small group of patients in every case the decrease or lack of acetazolamid reactivity was verified, and during the almost two-year follow-up period no cerebral stroke happened. The role of surgical intervention in this case is questionable. According to observations, reserve capacity decrease is not a permanent phenomenon. Following occlusive disease of the big cerebral arteries the spontaneous improvement of the damaged haemodinamics depends greatly on the condition of the collateral circulation. With a patient suffering from systemic arteriosclerosis, not only on the level of the large arteries but also on the level of the medium-sized and small arteries, the disease can manifest itself. In cases like this, not in every case, expected the improvement of the reserve capacity following the endarterectomia performed on the carotis interna. Though our results did not reassure that the carotis endarterectomia has a positive effect on the cerebral reserve capacity, however, it had a preventive effect on the formation of cerebral stroke. It is assumable that if we know the state of the cerebral circulation of the patients better, those with greater risk of cerebral ischemia can be filtered, this way their treatment and follow-up monitoring can be made safer. The quantitative non-invasive SPECT measurement of the cerebral perfusion reserve and the monitoring of the efficacy of the various treatments in everyday practice are advisable for patients suffering from cerebral vasoocclusive disease. An intensive increase has been observed in recent years also in national practice in the number of revascularization intervention in carotis arteries including interventions, too. This is why there would be an even greater need for performing multipolar studies for monitoring the changing of cerebral perfusion reserve capacity following carotis surgery, either on symptom-free patients or on patients with symptoms. ISOTOPE HAND-CIRCULATION EXAMINATIONS: I. Applying STATIC HAND-PERFUSION with Tc-99m-DTPA for the examination of "cold hands". a. Data gathering: The examination does not need any preparation. The patient lies on the back under the gamma camera with hands raised above the head, fingers together, palm on the surface of the collimator. In a vein in the back of the leg we injected 400 MBq 99mTcDTPA dietilen triamin-pentaacetat ; bolus-like. The images were taken with low-energy parallel caliber colliamator-applied with an MB 9200-type gamma camera Gamma Works ; . Simultaneously with the injection, we started a 60 X series of images, then immediately after the setting in of the balanced state we took a three-minute-long static image. b. Image processing: We used two images for the computerized ROI marking, the total image of the first 60 7 and taxotere.
Paclitaxel taxol
USDA-Plants Database 2006 ; Map of the USA. : plants da.gov java profile?symbol SOEL [accessed in February 2006]. Details are provided for California, Utah, Kansas, Arkansas, Illinois, Tennessee, Georgia, North Carolina, South Carolina and Florida. Hawaiian Ecosystems at Risk Project 2004 ; Known distribution of S. elaeagnifolium in Hawaii. : hear maps plants hawaii solanum elaeagnifolium [accessed in February 2006].
4. Cavaletti, G., Pezzoni, G., Pisano, C., Oggioni, N., Sala, F., Zoia, C., Ferrarese, C., Marmiroli, P., and Tredici, G. Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor. Neurosci. Lett., 322: 103106, 2002. Apfel, S. C. Neurotrophic factors in peripheral neuropathies: therapeutical implications. Brain Pathol., 9: 393 413, Apfel, S. C., Arezzo, J. C., Lipson, L. A., and Kessler, J. A. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol., 31: 76 80, Schmidt, Y., Unger, I., Bartke, R., and Reiter, R. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic cd db ; mice. Exp. Neurol., 132: 16 23, Tredici, G., Braga, M., Nicolini, G., Miloso, M., Marmiroli, P., Schenone, A., Nobbio, L., Frattola, L., and Cavaletti, G. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats. Exp. Neurol., 159: 551558, 1999. Moos, P. J., and Fitzpatrick, F. A. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc. Natl. Acad. Sci. USA, 95: 3896 3901, Apfel, S. C., Lipton, R. B., Arezzo, J. C., and Kessler, J. A. Nerve growth factor prevents toxic neuropathy in mice. Ann. Neurol., 29: 8790, 1991. Fritz, I. B. Carnitine and its role in fatty acid metabolism. Adv. Lipid Res., 1: 285334, 1963. Bremer, J. Carnitine metabolism and functions. Physiol. Rev., 63: 1420 1480, Stanley, C. A. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv. Pediatr., 34: 59 88, Bieber, L. L. Carnitine. Annu. Rev. Biochem., 57: 261283, 1988. Lowitt, S., Malone, J. I., Salem, A. F., and Korthals, J., Benford, S. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism, 44: 677 680, Di Giulio, A. M., Lesma, E., and Gorio, A. Diabetic neuropathy in the rat: 1. ALC augments the reduced levels and axoplasmic transport of substance P. J. Neurosci. Res., 40: 414 419, Kano, M., Kawakami, T., Hori, H., Hashimoto, Y., Tao, Y., Ishikawa, Y., and Takenaka, T. Effects of ALC on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats. Neurosci. Res., 33: 207213, 1999. Fernandez, E., Pallini, R., Tamburrini, G., Lauretti, L., Tancredi, A., and La Marca, F. Effects of levo-acetylcarnitine on second motoneuron survival after axotomy. Neurol. Res., 17: 373376, 1995. Piovesan, P., Pacifici, L., Taglialatela, G., Ramacci, M. T., and Angelucci, L. Acetyl-L-carnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria-fornix transection. Brain Res., 633: 77 82, Foreman, P. J., Perez-Polo, J. R., Angelucci, L., Ramacci, M. T., and Taglialatela, G. Effect of Acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor p75NGFR ; mRNA level in the central nervous system of aged rats. Prog. Neuropsychopharmacol. Biol. Psych., 19: 117133, 1995. Fanti, L., Berloco, M., and Pimpinelli, S. Carnitine suppression of position-effect variegation in Drosophila melanogaster. Mol. Gen. Genet., 244: 588 595, Pomponi, M. G., and Neri, G. Butyrate and Acetyl-l-carnitine inhibit the Cytogenetic expression of the fragile X in vitro. Am. J. Med. Gen., 51: 447 450, Cavaletti, G., Cavalletti, E., Montaguti, P., Oggioni, N., De Negri, O., and Tredici, G. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology, 18: 137146, 1997. Cavaletti, G., Tredici, G., Marmiroli, P., Petruccioli, M. G., Barajon, I., and Fabbrica, D. Morphometric study of the sensory neurones and peripheral nerve changes induced by chronic cisplatin DDP ; administration. Acta Neuropathol., 84: 364 371 and tazorac.
Taxol mechanism
Platin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 360-67 O'Rourke M, Crawford J, Schiller J, Laufman L, Yanovich S, Ozer H, et al. Survival advantage for patients with stage IV NSCLC treated with single agent navelbine in a randomized controlled trial [abstract]. Proc Soc Clin Oncol 1993; 12: 343 Chang AY, Kim K, Glick J, Anderson T, Karp D, Johnson D. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: the Eastern Cooperative Oncology Group Results. J Natl Cancer Inst 1993; 85: 388-94 Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Gross HM, et al. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 384-88.
Different minimum safe temperatures. Poultry--165 Chopped Ground Meat--155 Steaks and Roasts--145 Fish--145 "Meat should maintain the target temperature for two full minutes in order to kill any harmful bacteria, " says Kenneth Smith, CEC, CDM, director of nutrition services at Regional Medical Center of San Jose. "Purchase a quality meat thermometer and read the directions carefully." PRACTiCe SAFe FooD PRePARATion. Wash your hands and your knife in warm, soapy water for 20 seconds after contact with meat. Use color-coded cutting boards for each type of food or purchase cutting boards with pictures of vegetables, poultry or beef. SToRe leFToVeRS CAReFully. Cooked food should be refrigerated to 70 degrees within two hours and to 40 degrees within four hours. Transfer food from deep pots to shallow containers with vented lids until food has cooled adequately. "Bacteria grows rapidly when meat temperature is between 40 and 145 degrees, " says Smith. "Meat can only remain in that danger zone for about two hours before it becomes unsafe to eat and telithromycin.
Effect of organic solvent used for lyophilization and drug on the stability of plga in lyophilized sponges at 4, 25, and 40c leu: leuprolide; lido: lidocaine.
National Institute of Mental Health 2005 ; . Medications. Bethesda MD ; . National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services and temodar.
With peripheral blood progenitor support in women with responding metastatic breast cancer. Clin Cancer Res 1998; 4: 1689-95. Iniguez C, Larrode P, Mayordomo Jl et al. Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel. Neurology 1998; 51: 868-70. Stemmer SM, Cagnoni PJ, Shpall EJ et al. High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: A phase I trial. J Clin Oncol 1996; 14: 1463-72. Rowinsky EK, Eisenhauer EA, Chaudry Vet al. Clinical toxicities encountered with paclitaxel Taxol ; . Semin Oncol 1993; 20 Suppl 3 ; : 1-15. Postma TJ, Vermorken JB, Liefting AJM et al. Paclitaxel-induced neuropathy. Ann Oncol 1995; 6: 489-94. Lipton RB, Apfel SC, Dutcher JPet al. Taxol produces a predominantly sensory neuropathy. Neurology 1989; 39: 368-73. Wiernik PH, Schwartz EL, Strauman JJ et al. Phase I clinical and pharmacokinetic study of Taxol. Cancer Res 1987; 47: 2486-93. Forsyth PA, Balmaceda C, Peterson K et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neuro-Oncol 1997; 35: 47-53. van Gerven JMA, Moll JWB, van den Bent MJ et al. Paclitaxel Taxol ; induces cumulative mild neurotoxicity. Eur J Cancer 1994; 30A: 1074-7. Cavaletti GC, Bogliun G, Marzorati L et al. Peripheral neurotoxicity of Taxol in patients previously treated with cisplatin. Cancer 1995; 75: 1141-50. Berger T, Malayeri R, Doppelbauer A et al. Neurological monitoring of neurotoxicity induced by paclitaxel-cisplatin chemotherapy. Eur J Cancer 1997; 33: 1393-9. Keane JR. Bilateral seventh nerve palsy: Analysis of 43 cases and review of the literature. Neurology 1994; 44: 1198-202. Cwach H, Landis J, Freeman JW. Bilateral seventh nerve palsy: A report of two cases and a review. S D J Med 1997; 50: 99-101. Arias G, Nogues J, Manos M et al. Bilateral facial nerve palsy: Four case reports. ORL J Otorhinolaryngol Relat Spec 1998; 60: 227-9. Balmaceda C, Hesdorffer CS, Lange D et al. Neurotoxicity associated with high-dose paclitaxel chemotherapy. Proc Soc Clin Oncol 1997; 16: 222a Abstr 778 ; . Adour KK, Byl FM, Hilsinger RL et al. The true nature of Bell's palsy: Analysis of 1000 consecutive patients. Laryngoscope 1978; 88: 787-801. Capri G, Munzone E, Tarnzi E et al. Optic nerve disturbances: A new form of paclitaxel neurotoxicity. J Natl Cancer Inst 1994; 86: 1099-101. Willey J, Ibrahim NK, Walters R et al. Vocal cord paralysis secondary to biweekly vinorelbine and paclitaxel by simultaneius three-hour infusin with G-CSF support as frontline therapy for metastatic breast cancer patients. Proc Soc Clin Oncol 1998; 17: 183a Abstr 704 ; . Boyle F, Monk R, Davey R et al. Prevention of experimental paclitaxel neuropathy with glutamate. Proc Assoc Can Res 1996; 37: 290 Abstr 1974 ; . Savarese D, Boucher J, Corey B. Glutamine treatment of paclitaxel-induced myalgias and arthralgias. J Clin Oncol 1998; 16: 3918-9.
Carboplatinum and taxol
Taxol ; caused by P-glycoprotein Sci. USA, 94: 2031-2035, 1997 and tenex.
With the use of taxol treatment we have found that the human oocyte develops an abundance of MTOCs in the cortex of the cell as it progresses from prophase I to metaphase II of meiosis. The appearance of MTOCs coincides with the period of assembly of the meiotic spindles for both meiotic divisions. Interestingly, the number and distribution of these domains far exceeds what is apparently necessary for spindle assembly if indeed some of them are recruited for meiotic spindle assembly. We observed that the first microtubule nucleating sites appeared near the prophase nucleus as the oocyte began to leave prophase arrest, during GVBD. Although our data only quantify MTOC numbers in a single defined cross-section of the oocyte, it is clear that hundreds of MTOCs appear in the egg cortex as MI and Mil are established. Our data with the human oocyte are in accord with what has been reported about MTOC disposition in animal models. In mouse oocytes, taxol has revealed that numerous MTOCs exist in the oocyte cortex during various stages of maturation, but most prevalently during meiotic metaphase Maro et al, 1985; Rime et al, 1987; Messinger and Albertini, 1991; Schatten et al, 1992 ; . In these rodent oocytes, astral arrays of microtubules can be observed throughout the cortex, reminiscent of the pattern we observed in the human oocyte. Maro et al. 1985 ; calculated that the mouse oocyte manifests up to a total of 24 MTOC domains oocyte after taxol treatment. Our data obtained only from equatorial segments appear to indicate that the human oocyte develops far more MTOCs during meiotic maturation than the mouse. However, since the dosages of taxol and the length of treatment vary considerably in these studies it is difficult to compare the results of experiments with the human and mouse oocytes. Our dosage and treatment duration was developed to optimize MTOC visualization, not as a direct comparison to the studies with animal models. There is evidence that oocytes may recruit MTOCs during germinal vesicle breakdown GVBD ; to become the progenitors of the meiotic spindle Calarco et al, 1972; Albertini, 1987; Mattson and Albertini, 1990; Messinger and Albertini, 1991 ; . It appears that the unpolymerized pool of tubulin within the oocyte cortex is in a very dynamic state and is dependent upon interaction with the MTOCs for controlled polymerization. By observing normal spindle assembly during various phases of meiosis in the human oocyte, we have found that microtubule polymerization, presumably modulated by centrosomal activity, is first apparent adjacent to the prophase nucleus Battaglia et al, 1996 ; . The number of microtubule nucleating sites increases as the meiotic spindles become organized. These data, coupled with our current observations after taxol treatment, support the concept that the centrosome in the human oocyte may also recruit MTOCs from a large cytoplasmic pool for meiotic spindle assembly. Our results differ significantly from an interesting report on the effects of taxol treatment on the human oocyte. Pickering et al. 1988 ; treated human oocytes with taxol at Mil of meiosis and reported the appearance of elongated microtubules only at the spindle poles, thus demonstrating the dynamic nature of the meiotic spindle. However, they observed only 849.
Carbo taxol for lung cancer
TAXOL * is used to treat cancer of the ovary, the breast, and non small cell cancer of the lung. Ask your doctor if you have any questions about why TAXOL * was prescribed for you and teniposide.
Figure 4. Taxol activates total pooled JNK in HEK 293 cells but not in cortical neurons. A, HEK 293 cells were treated with 250 nM taxol for the indicated times, and 100 g of cell lysates was used to measure total JNK activity by a JNK capture assay. B, C, Cortical neurons at DIV 6 were treated with 100 nM taxol for the indicated times in hours ; , and 100 g of cell lysates was used to measure JNK1 2 activity B ; or JNK3 activity C ; as described in Materials and Methods. Error bars indicate SD. D, Cortical neurons have much higher basal JNK activity in comparison with HEK 293 cells. Various amounts of cell lysates prepared from untreated cortical neurons or HEK 293 cells were used for anti-phospho-JNK Western blot analysis, indicative of JNK activation. Phospho-JNK was readily visible using as low as 5 g total lysates from unstimulated cortical neurons, whereas at least 100 200 g of total lysates from unstimulated HEK 293 cells was needed to see any JNK phosphorylation and taxol
Taxol recall
Chorionic villus sampling and amniocentesis, chronic disease medisave, anion with 18 electrons, vena cava filter and hoodia info. Crestor q10, abate ar, mometasone elica and benzene international or emergency code team members.
Taxol formula
Axol, atxol, taxok, tsxol, taxxol, yaxol, tadol, txol, taxlo, taaxol, tzxol, taol, tacol, taxpl, taxll, 6axol, tasol, tax0l, 5axol.
Effect of selenium in combination with adriamycin or taxol
Taxol efficacy, paclitaxel taxol, taxol mechanism, carboplatinum and taxol and carbo taxol for lung cancer. Taxol recall, taxol formula, effect of selenium in combination with adriamycin or taxol and carboplatin and taxol for breast cancer or taxol avastin carboplatin.
|
